selecting an optimal second-line regimen for mrcc
Published 5 years ago • 98 plays • Length 7:53Download video MP4
Download video MP3
Similar videos
-
6:36
choosing second-line therapy in treatment of mrcc
-
3:04
mrcc: factors for choosing second-line therapy
-
6:30
second-line therapy after i/o in mrcc
-
4:06
selecting second-line therapy for metastatic rcc
-
4:42
making decisions for second-line therapy in mrcc
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
7:49
what does your future hold?
-
50:32
imrt 2.0 | session 2 | infrastructure, hardware and software requirements
-
7:55
choosing upfront therapy for mrcc
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
7:36
mrcc patient selection for ipilimumab/nivolumab
-
0:59
dr. lee on second-line treatment options in rcc
-
7:07
selecting second-line agents in renal cell carcinoma
-
4:18
mrcc: how an approved i-o regimen impacts treatment
-
3:42
second-line combination therapy in mrcc
-
2:22
promising second-line therapies for mrcc
-
6:02
second and third-line decisions in rcc
-
9:05
mrcc: when is tki/i-o combination therapy appropriate?
-
4:05
therapy selection for patients with newly diagnosed mrcc
-
5:31
treatment plan criteria and second-line options
-
1:12
dr. agarwal on second-line therapy selection in metastatic rcc
-
10:17
strategies for switching from frontline therapy to second-line therapy in mrcc